Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Updated on: January 02,2024

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Updated on:January 02,2024

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and

Updated on: April 07,2024

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and

Updated on:April 07,2024

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on: January 12,2024

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on:January 12,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on: February 23,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on:February 23,2024

Men and women are different: Why medical oncology needs to restate the obvious

by European Society for Medical OncologyCredit: CC0 Public DomainGender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field&#

Updated on: March 12,2024

Men and women are different: Why medical oncology needs to restate the obvious

by European Society for Medical OncologyCredit: CC0 Public DomainGender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field&#

Updated on:March 12,2024

Study reveals insights into how cancer cells evade treatment

by Addison Dehaven,South Dakota State UniversityCancers use sugar residues to engage in multidrug resistance. The research conducted by the RAWC Lab reveals breakthrough insights into exactly ho

Updated on: February 01,2024

Study reveals insights into how cancer cells evade treatment

by Addison Dehaven,South Dakota State UniversityCancers use sugar residues to engage in multidrug resistance. The research conducted by the RAWC Lab reveals breakthrough insights into exactly ho

Updated on:February 01,2024

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl

Updated on: December 28,2023

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl

Updated on:December 28,2023

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco

Updated on: April 01,2024

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco

Updated on:April 01,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on: April 09,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on:April 09,2024

Novel AI blood test detects liver cancer

byJohns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainA novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center re

Updated on: January 15,2024

Novel AI blood test detects liver cancer

byJohns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainA novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center re

Updated on:January 15,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on: March 20,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on:March 20,2024

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Updated on: January 22,2024

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Updated on:January 22,2024